EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression

E Catanzaro, M Peviani, E Bonaiuto, F Pezzato, M Benatti, C Cavaliere, N Perin, F P Russo, M Gambato, P Burra, A Floreani, R Motta und 1 weitere

Digestive and Liver Disease · 2026-07 · 58 (7) · 957-965

DOI: 10.1016/j.dld.2026.04.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2026-07. Verfasst von E Catanzaro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Gastroenterology Unit, Azienda Ospedale-Università Padova,…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Fibric Acids, Fenofibrate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padua.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingFibric AcidsFenofibrateHumansDisease ProgressionRetrospective StudiesFemaleMaleUrsodeoxycholic AcidAdultMiddle AgedPruritusDrug Therapy, CombinationTreatment OutcomeCholagogues and CholereticsAlanine TransaminaseBilirubin

Stichwörter der Autor:innen

Fibrate therapyMRI scoresPrimary sclerosing cholangitisPrognosis

Substanzen

Ursodeoxycholic AcidFibric AcidsFenofibrateCholagogues and CholereticsAlanine TransaminaseBilirubin

Autor:innen und Institutionen

  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Gastroenterology Unit, Azienda Ospedale-Università Padova, Padova, Italy; ERN RARE-LIVER - European Reference Network on Rare He…
  • Gastroenterology Unit, Azienda Ospedale-Università Padova, Padova, Italy; ERN RARE-LIVER - European Reference Network on Rare Hepatological Diseases.
  • ERN RARE-LIVER - European Reference Network on Rare Hepatological Diseases; Gastroenterology and Digestive Endoscopy Unit, AULSS1 Dolomiti Veneto, Feltre, Belluno, Italy.
  • Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
  • Department of Internal Medicine, Mirano Hospital, ULSS 3 Serenissima, Mirano, Venice, Italy.
  • Gastroenterology Unit, Azienda Ospedale-Università Padova, Padova, Italy; Multivisceral Transplant Unit, Azienda Ospedale - Università Padova, Padova, Italy.

Förderung

  • University of Padua

Zitieren

APA

Catanzaro, E., Peviani, M., Bonaiuto, E., Pezzato, F., Benatti, M., Cavaliere, C., Perin, N., Russo, F. P., Gambato, M., Burra, P., Floreani, A., Motta, R., & Cazzagon, N. (2026). Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression. Digestive and Liver Disease, 58(7), 957-965. https://doi.org/10.1016/j.dld.2026.04.017

Vancouver

Catanzaro E, Peviani M, Bonaiuto E, Pezzato F, Benatti M, Cavaliere C, et al. Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression. Digestive and Liver Disease. 2026;58(7):957-965. doi:10.1016/j.dld.2026.04.017

BibTeX
@article{Catanzaro2026,
  author = {Catanzaro, E and Peviani, M and Bonaiuto, E and Pezzato, F and Benatti, M and Cavaliere, C and Perin, N and Russo, F P and Gambato, M and Burra, P and Floreani, A and Motta, R and Cazzagon, N},
  title = {Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression},
  journal = {Digestive and Liver Disease},
  year = {2026},
  volume = {58},
  number = {7},
  pages = {957--965},
  doi = {10.1016/j.dld.2026.04.017}
}
Kostenlos starten →